Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$17,500.00
Intranasal Fentanyl for Procedural Analgesia during Peripherally Inserted Central Catheter Placement in Very Preterm Infants
FY 2022-23
Summary
Premature newborns admitted to the neonatal intensive care unit are exposed to multiple medical procedures per day. These procedures are essential but may also cause pain. A common painful procedure is the insertion of an intravenous line (a tube placed inside a vein) to give medications and nutrition support. Preventing or decreasing pain associated with procedures is important for the newborn’s care and long-term development. The insertion of an intravenous line is a procedure causing moderate to severe pain where newborns would benefit from a medication for pain relief. Currently, they only receive behavioural pain management strategies, such as being held in a comfortable position, because previous studies were not able to find the optimal medication that is both safe and effective. At this time, there is no standard medication used in the neonatal intensive care unit to manage pain associated with this medical procedure. For this reason, newborn pain has been reported to be under-treated. This study plans to explore the role of fentanyl (an opioid pain reliever) during intravenous line insertion. In combination with existing behavioural strategies, fentanyl will be sprayed directly into the newborn’s nose before the start of the procedure to prevent or reduce pain. This study aims to identify a safe and effective medication to lower pain as well as improve the care and wellbeing of hospitalized premature newborns. Study results will also increase our understanding of newborn pain management strategies.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
486150
Name
Tabbara Najla
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Intranasal Fentanyl for Procedural Analgesia during Peripherally Inserted Central Catheter Placement in Very Preterm Infants
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Fentanyl; Intranasal Drug Administration; Neonatal Intensive Care Unit; Peripherally Inserted Central Catheter Line Insertion; Preterm Infants; Procedural Pain
Abstract
Premature newborns admitted to the neonatal intensive care unit are exposed to multiple medical procedures per day. These procedures are essential but may also cause pain. A common painful procedure is the insertion of an intravenous line (a tube placed inside a vein) to give medications and nutrition support. Preventing or decreasing pain associated with procedures is important for the newborn’s care and long-term development. The insertion of an intravenous line is a procedure causing moderate to severe pain where newborns would benefit from a medication for pain relief. Currently, they only receive behavioural pain management strategies, such as being held in a comfortable position, because previous studies were not able to find the optimal medication that is both safe and effective. At this time, there is no standard medication used in the neonatal intensive care unit to manage pain associated with this medical procedure. For this reason, newborn pain has been reported to be under-treated. This study plans to explore the role of fentanyl (an opioid pain reliever) during intravenous line insertion. In combination with existing behavioural strategies, fentanyl will be sprayed directly into the newborn’s nose before the start of the procedure to prevent or reduce pain. This study aims to identify a safe and effective medication to lower pain as well as improve the care and wellbeing of hospitalized premature newborns. Study results will also increase our understanding of newborn pain management strategies.
Competitiondate
202212
Approvedterm2
1 yr 0 mth
Pinamesdelim
Tabbara, Najla
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~